Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials

The American Journal of Medicine
Toshiya ShigaRyo Ogawa

Abstract

Magnesium supplementation may reduce the incidence of arrhythmias, which often occur after cardiac surgery; however, recent findings of the effectiveness of magnesium prophylaxis have yielded discrepant results. We searched electronic databases for randomized controlled trials of magnesium for the prevention of arrhythmias after cardiac surgery. The primary outcomes comprised the incidence of supraventricular and ventricular arrhythmias, and the secondary outcomes comprised serum magnesium concentration, length of hospital stay, myocardial infarction, and mortality. Effect sizes were estimated using a random-effects model. Seventeen trials (n=2069 patients) met the inclusion criteria. Pooled serum magnesium concentration at 24 hours after surgery in the treatment group was significantly higher than that in the control group (weighted mean difference=0.45 mmol/L [1.1 mg/dL]; 95% confidence interval [CI]: 0.30 to 0.59 mmol/L [0.7 to 1.4 mg/dL]; P <0.001). Magnesium supplementation reduced the risk of supraventricular arrhythmias (relative risk [RR]=0.77; 95% CI: 0.63 to 0.93; P=0.002) and ventricular arrhythmias (RR = 0.52; 95% CI: 0.31 to 0.87; P <0.0001), but had no effect on the length of hospital stay (weighted mean differenc...Continue Reading

References

Jun 1, 1991·Journal of Cardiothoracic and Vascular Anesthesia·L S AglioB Chernow
Sep 11, 1991·The Annals of Thoracic Surgery·W J FanningW S Stoney
Jun 1, 1988·British Journal of Anaesthesia·M N HarrisC Aps
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Jan 1, 1985·The American Journal of Cardiology·B R HeckerR S Crampton
Apr 1, 1994·Journal of Cardiothoracic and Vascular Anesthesia·P A CasthelyM Kelly
Apr 1, 1995·Journal of Cardiothoracic and Vascular Anesthesia·J O WistbackaA Ruokonen
Apr 1, 1995·The Annals of Thoracic Surgery·J CaspiM Saute
Feb 1, 1995·The Annals of Thoracic Surgery·R Karmy-JonesA Koshal
Jan 1, 1993·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·I W ColquhounD J Wheatley
Nov 1, 1993·Clinical Cardiology·T FazekasR Lazzara
Sep 1, 1993·The Annals of Thoracic Surgery·L L CreswellJ L Cox
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
May 15, 1997·The New England Journal of Medicine·S R OmmenM S Stanton
Jan 1, 1997·Scandinavian Cardiovascular Journal : SCJ·B M JensenN A Klitgård
Dec 10, 1999·Southern Medical Journal·R Swain, B Kaplan-Machlis
Feb 2, 2000·The Annals of Thoracic Surgery·A J SolomonN M Katz
Apr 11, 2000·The Thoracic and Cardiovascular Surgeon·G SpezialeB Marino
Oct 31, 2000·Critical Care Medicine·M K Chung
Oct 31, 2000·Critical Care Medicine·G M Chaudhry, C I Haffajee
Dec 19, 2001·Annals of Internal Medicine·W H MaiselW G Stevenson
Feb 9, 2002·The Annals of Thoracic Surgery·Mark YeatmanGianni D Angelini
Sep 20, 2002·The Annals of Thoracic Surgery·Stefano ForlaniLuigi Chiariello
Feb 13, 2003·The Journal of Thoracic and Cardiovascular Surgery·Mehmet KaplanMahmut Murat Demirtas
May 28, 2003·International Journal of Cardiology·Ugursay KiziltepeHakki Akalin

❮ Previous
Next ❯

Citations

Sep 1, 2005·Pflügers Archiv : European journal of physiology·Hasan A AlmullaDavid Ellis
Jan 29, 2009·European Heart Journal·Diana KaireviciuteGregory Y H Lip
Dec 2, 2010·Journal of Cardiothoracic Surgery·Ioanna KoniariDimitrios Dougenis
Nov 27, 2007·Critical Care : the Official Journal of the Critical Care Forum·Mengalvio E SleeswijkJan G Zijlstra
Nov 2, 2005·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Daniel E HillemanStephanie Maciejewski
Jul 5, 2013·Avicenna Journal of Medicine·Ashraf MostafaTushar Tuliani
Oct 31, 2006·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Joel DunningUNKNOWN EACTS Audit and Guidelines Committee
Aug 18, 2005·Current Cardiology Reports·Orhan OnalanEugene Crystal
Apr 25, 2007·Scandinavian Cardiovascular Journal : SCJ·Hakala TapioHartikainen Juha
Oct 22, 2016·European Heart Journal. Cardiovascular Pharmacotherapy·William L Baker
May 3, 2005·Journal of the American College of Cardiology·Robert H Jones
May 17, 2005·Journal of the American College of Cardiology·Leonardo CalòMassimo Santini
Mar 22, 2007·The Annals of Pharmacotherapy·William L Baker, C Michael White
Dec 5, 2006·Current Opinion in Cardiology·L Brent Mitchell
Jul 20, 2007·Seminars in Dialysis·David M Spiegel
May 18, 2018·BMC Medicine·Susanna C LarssonKarl Michaëlsson
Dec 30, 2014·Physiological Reviews·Jeroen H F de BaaijRené J M Bindels
Jun 14, 2019·Cardiology Research and Practice·Paolo SeverinoFrancesco Fedele
Jun 5, 2013·Pacing and Clinical Electrophysiology : PACE·Harsha V GangaJeffrey Kluger
Sep 27, 2020·Antioxidants·Man Liu, Samuel C Dudley
Oct 11, 2020·Journal of Veterinary Emergency and Critical Care·Amber B SchoellerAndrew K Linklater
Nov 12, 2020·Journal of Brachial Plexus and Peripheral Nerve Injury·Siavash BeiranvandMaryam Baghizadeh Baghdashti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.